Amazon/Berkshire/J.P. Morgan Healthcare Partnership Seen as 'Potentially Formidable Combination' - Loop Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Anthem (ANTM) Appoints Bahija Jallal to Board
January 31, 2018 6:07 AM ESTAnthem, Inc. (NYSE: ANTM) announced today that Bahija Jallal, PhD, has been named to its Board of Directors effective February 1, 2018.
With more than 25 years of leadership experience and expertise in the biopharmaceutical industry, Dr. Jallals science-driven leadership combined with her passion to improve the lives of patients will be an asset to Anthems Board as they guide the Company... More
Amazon.com (AMZN) PT Maintained at $1,500 at Canaccord Genuity on 4Q Preview; 'Most Robust L-T Growth Opportunity in Internet Group'
January 30, 2018 12:20 PM ESTCanaccord Genuity maintained its price target on Amazon.com (NASDAQ: AMZN) at $1,500.00 while maintaining a Buy rating, ahead of the company's fourth quarter earnings announcement on Feb 1, after the market close.
Analyst Michael Graham suggests AMZN has the "most robust long-term growth... More
BofA/Merrill Lynch Reiterates Buy on Amazon (AMZN) Following Announced Health Care Partenership
January 30, 2018 11:50 AM ESTBofA/Merrill Lynch reiterated a Buy rating and $1460.00 price target on Amazon.com (NASDAQ: AMZN) following the company's announced partnership with Berkshire Hathaway and JPMorgan Chase & Co. with the goal of reducing health care costs over time. The companies state that this... More
